CUOMO, ROSARIO
 Distribuzione geografica
Continente #
AS - Asia 12.590
NA - Nord America 11.264
EU - Europa 9.218
SA - Sud America 1.638
AF - Africa 303
OC - Oceania 93
Continente sconosciuto - Info sul continente non disponibili 12
Totale 35.118
Nazione #
US - Stati Uniti d'America 10.785
SG - Singapore 5.789
RU - Federazione Russa 3.656
CN - Cina 2.201
VN - Vietnam 1.997
IT - Italia 1.497
BR - Brasile 1.331
HK - Hong Kong 1.136
UA - Ucraina 766
DE - Germania 674
FR - Francia 613
FI - Finlandia 468
IE - Irlanda 390
GB - Regno Unito 313
IN - India 313
JP - Giappone 260
SE - Svezia 232
NL - Olanda 226
CA - Canada 217
MX - Messico 166
BD - Bangladesh 126
AR - Argentina 109
PL - Polonia 94
TR - Turchia 90
PH - Filippine 84
ZA - Sudafrica 84
ES - Italia 81
AU - Australia 80
IQ - Iraq 80
ID - Indonesia 72
EC - Ecuador 61
CI - Costa d'Avorio 57
TH - Thailandia 56
PK - Pakistan 54
CO - Colombia 45
TW - Taiwan 41
SA - Arabia Saudita 40
KR - Corea 39
AT - Austria 29
BE - Belgio 28
VE - Venezuela 26
JO - Giordania 24
MA - Marocco 24
EG - Egitto 21
LT - Lituania 21
ET - Etiopia 20
IL - Israele 19
MY - Malesia 19
CL - Cile 18
DZ - Algeria 18
KE - Kenya 18
LB - Libano 18
NP - Nepal 18
UZ - Uzbekistan 18
JM - Giamaica 17
TN - Tunisia 17
CZ - Repubblica Ceca 16
AZ - Azerbaigian 15
IR - Iran 15
PY - Paraguay 14
BO - Bolivia 13
GR - Grecia 13
NZ - Nuova Zelanda 13
CR - Costa Rica 12
TT - Trinidad e Tobago 12
EU - Europa 11
PE - Perù 11
PT - Portogallo 11
RS - Serbia 11
AE - Emirati Arabi Uniti 10
RO - Romania 10
DK - Danimarca 8
DO - Repubblica Dominicana 8
PA - Panama 8
HN - Honduras 7
KZ - Kazakistan 7
NI - Nicaragua 7
OM - Oman 7
AO - Angola 6
LK - Sri Lanka 6
UY - Uruguay 6
AL - Albania 5
CH - Svizzera 5
GT - Guatemala 5
HR - Croazia 5
QA - Qatar 5
SK - Slovacchia (Repubblica Slovacca) 5
SN - Senegal 5
AM - Armenia 4
BA - Bosnia-Erzegovina 4
BY - Bielorussia 4
HU - Ungheria 4
KG - Kirghizistan 4
MD - Moldavia 4
MT - Malta 4
PR - Porto Rico 4
SI - Slovenia 4
ZW - Zimbabwe 4
BB - Barbados 3
BG - Bulgaria 3
Totale 35.034
Città #
Singapore 2.581
San Jose 1.374
Hong Kong 1.101
Moscow 945
Chandler 822
Jacksonville 807
Beijing 567
Ashburn 563
Ho Chi Minh City 494
Santa Clara 463
Hanoi 452
Millbury 442
Princeton 393
The Dalles 343
Lauterbourg 341
Nanjing 277
Los Angeles 274
Napoli 234
Tokyo 219
Wilmington 197
Naples 185
Buffalo 183
Boston 181
Woodbridge 176
Amsterdam 167
New York 138
Munich 131
Dallas 125
São Paulo 120
Council Bluffs 106
Dearborn 103
Ann Arbor 102
Dong Ket 100
Kronberg 92
Houston 90
Ottawa 89
Da Nang 87
Nanchang 86
Haiphong 74
Redondo Beach 74
Shenyang 72
Hefei 71
Des Moines 69
Mexico City 69
Seattle 69
Hebei 68
Frankfurt am Main 64
Orem 63
Warsaw 63
Milan 57
London 54
Rome 54
Changsha 53
Boardman 52
Norwalk 52
Denver 49
Tianjin 49
Jiaxing 45
Mumbai 45
Turku 44
Falls Church 43
Montreal 43
Brooklyn 41
Atlanta 38
Chicago 37
Hải Dương 37
San Francisco 37
Chennai 36
Helsinki 34
Rio de Janeiro 34
Baghdad 32
Bangkok 32
Johannesburg 32
Belo Horizonte 31
Phoenix 31
Shanghai 31
Falkenstein 30
Melbourne 30
Pune 29
Quito 28
Stockholm 28
Biên Hòa 27
Dublin 27
Brasília 26
Guangzhou 26
Redwood City 26
Nuremberg 25
Orange 25
Curitiba 24
Jakarta 24
Poplar 24
Thái Nguyên 22
Toronto 22
Amman 21
Kunming 21
Can Tho 20
Indiana 20
Gateshead 19
Addis Ababa 18
Brussels 18
Totale 17.609
Nome #
Effects of oral supplementation with the symbiotic (bifidobacterium longum w11 + fos actilight) on IBS with constipation: a randomized, dose finding trial, versus fibers, 593
La dispepsia post-infettiva: evoluzione sintomatologica- funzionale, predisposizione genetica, ruolo dell'Ossido Nitrico Sintetasi inducibile e coinvolgimento della glia entererica. 355
ADHERENCE TO MEDITERRANEAN DIET AND IBS SYMPTOMS IN ADOLESCENTS 227
Effect of carbonated drinks on upper digestive tract sensations and physiology in healthy subjects. 213
ALLELE-SPECIFIC TRANSCRIPTIONAL ACTIVITY OF THE VARIABLE NUMBER OF TANDEM REPEATS OF THE INDUCIBLE NITRIC OXIDE SYNTHASE GENE IS ASSOCIATED WITH IDIOPATHIC ACHALASIA 201
Sleeve gastrectomy-induced weight loss in severe obesity did not modify perception, intensity and pleasantness of basic tastes 197
null 179
Enteric Glia Stimulates Inflammation-Induced Responses in Human Intestine and Interacts with Immune Cells via S100B Protein 168
SPECIFIC DYSPEPTIC SYMPTOMS ARE ASSOCIATED WITH POOR RESPONSE TO THERAPY IN PATIENTS WITH GASTROESOPHAGEAL REFLUX DISEASE 163
Bacterial stimuli activate nitric oxide colonic mucosal production in diverticular disease. Protective effects ofL. casei DG® (Lactobacillus paracaseiCNCM I-1572) 162
The astroglial-derived S100 Beta protein stimulates the expression of nitric oxide synthase in rodent macrophages through p38 MAP kinase activation. 159
Altered taste perception in patients with gastroesophagealreflux disease 159
Sweetened carbonated drinks do not alter upper digestive tract physiology in healthy subjects 158
Quantitative analysis of aldolase A mRNA in liver discriminates between hepatocellular carcinoma and cirrhosis. 157
EARLY CHANGES IN HRM-OESOPHAGEAL PARAMETERS IN PRE AND POST TREATMENT ACHALASIA PATIENTS 157
Partially hydrolyzed guar gum in the treatment of irritable bowel syndrome with constipation: effects of gender, age, and body mass index 155
Probiotic and Postbiotic Effects of Lactobacillus Casei DG on Enteroglial-Derived S100B and Nitric Oxide Production in Human Intestinal Biopsies 152
Palmitoylethanolamide Exerts Antiproliferative Effect and Downregulates VEGF Signaling in Caco-2 Human Colon Carcinoma Cell Line Through a Selective PPAR-α-Dependent Inhibition of Akt/mTOR Pathway 151
Eosinophilic esophagitis: From pathophysiology to treatment. 151
Diagnosis and Treatment of Multiple Intestinal Angioectasias: A Case Report 151
Mild dehydration in dyspeptic athletes is able to increase gastrointestinal symptoms: Protective effects of an appropriate hydration 151
CHRONIC CONSTIPATION IS A RISK FACTOR FOR METABOLIC SYNDROME 149
Quality of bowel cleansing in hospetalized patients undergoing colonoscopy: a multicenter prospective regional study 147
S100B protein in the gut: the evidence for enteroglial-sustained intestinal inflammation. 146
Antibiotic-induced microbiota perturbation causes gut endocannabinoidome changes, hippocampal neuroglial reorganization and depression in mice 146
CO2 Modulates the Central Neural Processing of Sucrose Perception 146
Esofago di Barrett 145
Rifaximin improves Clostridium difficile toxin A-induced toxicity in Caco-2 cells by the PXR-dependent TLR4/MyD88 /NF-?B pathway 145
Impaired post-reflux swallow-induced peristaltic wave in severe obesity and implication in esophageal hyposensitivity 145
TASTE DISORDERS IN PATIENTS WITH GASTROESOPHAGEALREFLUX DISEASE 144
PHENYLTHIOCARBAMIDE TASTING STATUS AFFECTS QUININE-MEDIATED REDUCTION OF FOOD INTAKE 144
Body position may change high resolution manometry parameters and drift therapeutic choice in achalasia patients 144
Cannabidiol restores intestinal barrier dysfunction and inhibits the apoptotic process induced by Clostridium difficile toxin A in Caco-2 cells 142
HIV-1 Tat-induced diarrhea is improved by the PPARalpha agonist, palmitoylethanolamide, by suppressing the activation of enteric glia 141
Acetonic Extract from the Feijoa sellowiana Berg. Fruit Exerts Antioxidant Properties and Modulates Disaccharidases Activities in Human Intestinal Epithelial Cells 140
ACETONIC EXTRACT FROM FEIJOA SELLOWIANA BERG.FRUITS INHIBITS PROLIFERATION, MODULATES BRUSH BORDERMEMBRANE ENZYMES ACTIVITIES AND PREVENT LIPID PEROXIDATIONIN HUMAN INTESTINAL EPITHELIAL CELLS 140
Medical treatment of gastro-oesophageal reflux disease. 139
Iron Absorption following a Single Oral Dose of Ferrous Sulfate or Ferric Gluconate in Patients with Gastrectomy 138
Esophageal sensitivity and impaired post-reflux swallow-induced peristaltic wave are dependent by body mass index and acid exposition 138
Effect of enteroglial-derived S100B protein on human peripheral and mucosal immune cells’ functions 135
GERD IS A PROTECTIVE RISK FACTOR FOR HYPERTENSION 135
Incidence and distribution of coeliac disease in Campania (Italy): 2011-2013 135
Pathophysiology of gastro-oesophageal reflux disease. 134
La proteina di derivazione enterogliale S100B stimola la produzione di ossido nitrico nella colite ulcerosa. 134
Postprandial Gastrointestinal Function Differs after Acute Administration of Sourdough Compared with Brewer's Yeast Bakery Products in Healthy Adults 134
A patient with oeosinophilic gastroenteritis and severe malnutrition improved with home parenteral nutrition 133
DOES STANDARDIZED DIET IMPROVE PROTON PUMP INHIBITOR RESPONSE IN GERD PATIENTS? 133
The bitter taste receptor agonist quinine reduces calorie intake and increases the postprandial release of cholecystokinin in healthy subjects 133
ACHALASIA TREATMENT IMPROVES SPECIFIC SYMPTOMS AND QUALITY OF LIFE: VALIDATION OF AN ACHALASIA SPECIFIC QUALITY OF LIFE QUESTIONNAIRE 132
Ketogal: A Derivative Ketorolac Molecule with Minor Ulcerogenic and Renal Toxicity 132
Impaired Enterohormone Response Following a Liquid Test Meal in Gastrectomized Patients 132
CO2 modulates the central neural processing of sweet perception: an fMRI study 131
Enteric Glial Protein S100b Up-Regulation Stimulates Nitric Oxide Production in Ulcerative Colitis. 130
6 months-treatment of symptomatic uncomplicated diverticular disease of the colon with Lactobacillus paracasei F19 130
THE MEDITERRANEAN DIET IS A PROTECTIVE FACTOR AGAINST GASTROINTESTINAL SYMPTOMS IN YOUNG PEOPLE 130
CORRELATES TO ABDOMINAL PAIN IN CONSTIPATION PREVALENT IBS PATIENTS 130
Enteric glia: A new player in inflammatory bowel diseases 130
Genome-wide analysis of 53,400 people with irritable bowel syndrome highlights shared genetic pathways with mood and anxiety disorders 129
Effect of enteroglial-derived S100B protein on proliferation and responses in human peripheral and mucosal immune cells 129
PPI general practitioners’prescribing in the treatment of acid-related disorders: the impact of generic PPI launch into the pharmaceutical market in Italy 129
Cortical representation of different taste modalities on the gustatory cortex: A pilot study 129
Gastroesophageal reflux disease (GERD) cost of care: Role of naive and relapsed symptoms in general practice 128
THE ENTEROGLIAL DERIVED-S100B PROTEIN MEDIATES THEPROTECTIVE EFFECT OF LACTOBACILLUS CASEI DG ON LPS-INDUCEDNITRIC OXIDE PRODUCTION IN HUMAN INTESTINAL BIOPSIES 128
Autoimmune comorbidities in idiopathic achalasia 128
Rationale and evidences for treatment of symptomatic uncomplicated diverticular disease 128
Esophageal Acid Exposure and Altered Neurocardiac Function in Patients with GERD and Idiopatic Cardiac Arrhythmias 127
The Impact of Social and Cultural Engagement and Dieting on Well-Being and Resilience in a Group of Residents in the Metropolitan Area of Naples 127
Genetic contribution to motility disorders of the upper gastrointestinal tract. 126
Proton pump inhibitors prescribing following the introduction of generic drugs 125
Palmitoylethanolamide Modulates Inflammation-Associated Vascular Endothelial Growth Factor (VEGF) Signaling via the Akt/mTOR Pathway in a Selective Peroxisome Proliferator-Activated Receptor Alpha (PPAR-α)-Dependent Manner 124
Gastro-duodenal lesions and Helicobacter pylori infection in dyspeptic patients with and without chronic renal failure 123
Association between ccttt pentanucleotide repeat in the inducible nitric oxide synthase promoter polymorphism and achalasia 123
PARTIALLY HYDROLYZED GUAR GUM (PHGG) IN THE TREATMENT OF IRRITABLE BOWEL SYNDROME (IBS) WITH CONSTIPATION: EFFECTS OF GENDER, AGE AND BODY MASS INDEX (BMI) 122
Irritable bowel syndrome and food interaction. 122
Rifaximin, a non-absorbable antibiotic, inhibits the release of pro-angiogenic mediators in colon cancer cells through a pregnane X receptor-dependent pathway. 122
I livelli tessutali di grelina non correlano con il tempo di svuotamento gastrico 121
Influence of generic drugs on proton pump inhibitor prescription in primary care. 121
Influenza dei farmaci generici sulle dinamiche prescrittive degli inibitori di pompa protonica in medicina generale 121
Proton pump inhibitors market in primary care setting. 121
Gastric determinants of maximum satiety induced by standardized solid and liquid meal. An MRI study in non obese healthy subjects 119
THE ENTEROGLIAL-DERIVED S100B PROTEIN CONTROLSHUMAN INTESTINAL EPITHELIAL CELLS DIFFERENTIATION ANDPROLIFERATION VIA RAGE INTERACTION 119
PRESENCE OF ATYPICAL AND PAINFUL SYMPTOMS CORRELATES WITH LOW BMI AND POOR QUALITY OF LIFE IN GERD PATIENTS 119
Chronic constipation diagnosis and treatment evaluation: The "CHRO.CO.DI.T.E." study 119
Cannabidiol reduces intestinal inflammation through the control of neuroimmune axis. 118
Effects of long-term PPI treatment on producing bowel symptoms and SIBO 118
Role of Human Enteroglial Cells in Mediating Pathogenic and Probiotic Bacteria Effects on Intestinal Epithelial Cells 118
Palmitoylethanolamide improves colon inflammation through an enteric glia/toll like receptor 4-dependent PPAR-activation. 117
Galactosylated prodrugs of non-steroidal anti-inflammatories with improved pharmacokinetic characteristics and reduced toxicity of the starting drug 117
TASTE ALTERATIONS IN PATIENTS WITH GASTROESOPHAGEAL REFLUX DISEASE 116
Molecular Signaling and Dysfunction of the Human Reactive Enteric Glial Cell Phenotype: Implications for GI Infection, IBD, POI, Neurological, Motility, and GI Disorders 116
CORRELATION BETWEEN HIGH RESOLUTION MANOMETRY PARAMETERS AND SYMPTOMS IN TREATED ACHALASIA PATIENTS 116
Mechanisms underlying duodeno-gastric reflux in man. 115
Dyspeptic symptoms improvement in patients with non-erosive reflux disease is correlated with the degree of intragastric acid inhibition. 115
Correlation between oesophageal acid exposure and dyspeptic symptoms in patients with nonerosive reflux disease. 115
Effects of carbonated water on functional dyspepsia and constipation. 114
The role of a pre-load beverage on gastric volume and food intake: comparison between non-caloric carbonated andnon-carbonated beverage 114
BITTER TASTE RECEPTOR AGONIST AFFECTS FOOD INTAKEIN HEALTHY SUBJECTS 114
Almost all irritable bowel syndromes are post-infectious and respond to probiotics: consensus issues. 113
La gestione della malattia acido correlata nella medicina di primo livello. Sinergie di utilizzo degli archivi informatizzati per l’informatizzati per l’informazione e la formazione e la formazione professione. 113
IRON ABSORPTION AFTER SINGLE ORAL DOSE OF FERROUS SULFATE OR FERRIC GLUCONATE IN PATIENTS WITH TOTAL GASTRECTOMY: PRELIMINARY DATA 113
Totale 14.312
Categoria #
all - tutte 112.803
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 112.803


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021317 0 0 0 0 0 0 0 0 0 0 203 114
2021/20222.004 23 11 9 10 22 115 26 72 404 79 420 813
2022/20232.025 420 143 37 160 227 235 20 190 289 172 101 31
2023/20241.588 39 209 164 114 66 117 58 210 39 52 341 179
2024/20259.021 552 663 46 94 257 423 839 509 1.089 861 2.836 852
2025/202615.259 1.926 939 1.461 1.345 2.616 648 1.586 1.098 2.085 1.161 394 0
Totale 35.598